English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Ruth de Jauregui | Jun 4, 2017

National Institute of Health announces promising influenza study tool

Tabitha Fleming | Jun 2, 2017

European Commission approves dinutuximab beta for treating high-risk neuroblastoma

Ruth de Jauregui | Jun 2, 2017

Phase III trials of Ofev show positive results for idiopathic pulmonary fibrosis patients

Carrice Quinnie | Jun 2, 2017

Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis

LocalLabs News Service | May 31, 2017

K2M Group upgrades surgical device for spinal procedures

Ruth de Jauregui | May 31, 2017

Boehringer Ingelheim trial shows tiotropium Respimat improves breathing for asthma patients

Ruth de Jauregui | May 30, 2017

AstraZeneca announces top-line results in EXSCEL Phase IIIb/IV trial of Bydureon in diabetes patients

Robert Hadley | May 29, 2017

Amgen says Repatha an improvement over standard statin treatment

Trending

Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'

Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment

+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects

+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'

  • « First
  • «
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily